| CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV P Rajpurkar, C O’Connell, A Schechter, N Asnani, J Li, A Kiani, RL Ball, ... NPJ digital medicine 3 (1), 115, 2020 | 95 | 2020 |
| CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz R Griesel, G Maartens, M Chirehwa, S Sokhela, G Akpomiemie, ... Clinical Infectious Diseases 73 (11), e3902-e3909, 2021 | 75 | 2021 |
| Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual … DA Barr, JM Lewis, N Feasey, C Schutz, AD Kerkhoff, ST Jacob, ... The Lancet infectious diseases 20 (6), 742-752, 2020 | 53 | 2020 |
| Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis S Wasserman, ME Engel, R Griesel, M Mendelson BMC infectious diseases 16, 1-9, 2016 | 53 | 2016 |
| Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen CM Keene, R Griesel, Y Zhao, Z Gcwabe, K Sayed, A Hill, T Cassidy, ... Aids 35 (9), 1423-1432, 2021 | 40 | 2021 |
| Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV‐positive individuals DJ Van Hoving, R Griesel, G Meintjes, Y Takwoingi, G Maartens, ... Cochrane Database of Systematic Reviews, 2019 | 39 | 2019 |
| Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV TH Boyles, R Griesel, A Stewart, M Mendelson, G Maartens International Journal of Infectious Diseases 75, 67-73, 2018 | 38 | 2018 |
| C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients … F Mendelson, R Griesel, N Tiffin, M Rangaka, A Boulle, M Mendelson, ... BMC infectious diseases 18, 1-11, 2018 | 36 | 2018 |
| Optimizing tuberculosis diagnosis in human immunodeficiency virus–infected inpatients meeting the criteria of seriously ill in the World Health Organization algorithm R Griesel, A Stewart, H van der Plas, W Sikhondze, MX Rangaka, ... Clinical Infectious Diseases 66 (9), 1419-1426, 2018 | 33 | 2018 |
| Etiology of Pulmonary Infections in Human Immunodeficiency Virus–infected Inpatients Using Sputum Multiplex Real-time Polymerase Chain Reaction G Maartens, R Griesel, F Dube, M Nicol, M Mendelson Clinical Infectious Diseases 70 (6), 1147-1152, 2020 | 26 | 2020 |
| Abdominal ultrasound for the diagnosis of tuberculosis among human immunodeficiency virus-positive inpatients with World Health Organization danger signs R Griesel, K Cohen, M Mendelson, G Maartens Open forum infectious diseases 6 (4), ofz094, 2019 | 19 | 2019 |
| Prognostic indicators in the World Health Organization’s algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis R Griesel, A Stewart, H van der Plas, W Sikhondze, M Mendelson, ... AIDS research and therapy 15, 1-9, 2018 | 18 | 2018 |
| Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial R Griesel, Y Zhao, B Simmons, Z Omar, L Wiesner, CM Keene, AM Hill, ... The Lancet HIV 10 (7), e433-e441, 2023 | 15 | 2023 |
| Concentration–response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy R Griesel, AN Kawuma, R Wasmann, S Sokhela, G Akpomiemie, ... British journal of clinical pharmacology 88 (3), 883-893, 2022 | 15 | 2022 |
| Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks CM Keene, T Cassidy, Y Zhao, R Griesel, A Jackson, K Sayed, Z Omar, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 92 (5), 422-429, 2023 | 10 | 2023 |
| Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization’s algorithm for seriously ill HIV-infected … G Maartens, R Griesel, AP Kengne, F Dube, M Nicol, S Stewart, ... Southern African Journal of HIV Medicine 19 (1), 1-6, 2018 | 8 | 2018 |
| Antiretroviral therapy in second-line: investigating tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial Y Zhao, C Keene, R Griesel, K Sayed, Z Gcwabe, A Jackson, O Ngwenya, ... Wellcome Open Research 6, 2021 | 7 | 2021 |
| CheXaid: Deep learning assistance for physician diagnosis of tuberculosis using chest X-Rays in patients with HIV. npj Digital Medicine, 3: 115 P Rajpurkar, C O’Connell, A Schechter, N Asnani, J Li, A Kiani, RL Ball, ... Medical Imaging with Deep Learning, 728-744, 2020 | 7 | 2020 |
| Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial R Griesel, A Hill, G Meintjes, G Maartens Wellcome open research 6, 2021 | 6 | 2021 |
| Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial Y Zhao, R Griesel, Z Omar, B Simmons, A Hill, G Van Zyl, C Keene, ... Clinical Infectious Diseases 76 (10), 1832-1840, 2023 | 5 | 2023 |
